Trademark Overview
On Tuesday, January 14, 2025, a trademark application was filed for CHEMRNA with the United States Patent and Trademark Office. The USPTO has given the CHEMRNA trademark a serial number of 98960020. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, July 3, 2025. This trademark is owned by Convergence Bio, Inc.. The CHEMRNA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
pharmaceutical preparations, vaccines and medical therapeutics for the prevention and treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations, vaccines and medical therapeutics for improving the aging nervous system, aging cardiovascular system, aging respiratory system, aging gastrointestinal system, aging reproductive system, aging renal system, aging endocrine system, aging lymphatic system, aging immune system, aging muscular system, aging skeletal system, aging integumentary system, and for boosting energy, boosting vitality, promoting sleep, alleviating anxiety, enhancing memory and cognitive ability, and weight loss; vaccines for human use; nutritional and dietary supplements for improving the aging nervous system, aging cardiovascular system, ag...
research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies, pharmaceuticals and biopharmaceuticals; development of pharmaceutical preparations, vaccines and medicines; clinical studies; drug development and discovery; medical research for development of therapeutic modalities for treatment of diseases; assays and reagents for use in scientific and biomedical research; research and development of pharmaceutical preparations, vaccines and therapeutic drugs for the prevention and treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; research and development of therapeutic modalities for treatment of aging nervous system, aging cardiovascular system, aging respiratory system, aging gastroi...
